NO20051987L - Behandling av soppinfeksjoner. - Google Patents

Behandling av soppinfeksjoner.

Info

Publication number
NO20051987L
NO20051987L NO20051987A NO20051987A NO20051987L NO 20051987 L NO20051987 L NO 20051987L NO 20051987 A NO20051987 A NO 20051987A NO 20051987 A NO20051987 A NO 20051987A NO 20051987 L NO20051987 L NO 20051987L
Authority
NO
Norway
Prior art keywords
treatment
posaconazole
fungal infections
medicament
prevention
Prior art date
Application number
NO20051987A
Other languages
English (en)
Inventor
Rachel Courtney
Mark A Laughlin
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20051987L publication Critical patent/NO20051987L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Anvendelse av posakonazol for fremstillingen av et medikament for behandlingen eller forebyggingen av soppinfeksjoner hos mermesker som er 12 år gamle eller eldre og som har behov for slik behandling eller forebygging, der medikamentet omfatter en effektiv mengde av posakonazol i oppdelte doser to til fire ganger daghg for å oppnå en aritmetisk midlere steady-state-gj ermomsnittsplasmakonsentiasj on av posakonazol på minst 300 ng/ml til minst omtient 550 ng/mg blir tilkjermegjort.
NO20051987A 2002-09-23 2005-04-22 Behandling av soppinfeksjoner. NO20051987L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41298502P 2002-09-23 2002-09-23
PCT/US2003/029762 WO2004026303A2 (en) 2002-09-23 2003-09-19 Use of posaconazole for the treatment of fungal infections

Publications (1)

Publication Number Publication Date
NO20051987L true NO20051987L (no) 2005-04-22

Family

ID=32030948

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051987A NO20051987L (no) 2002-09-23 2005-04-22 Behandling av soppinfeksjoner.

Country Status (11)

Country Link
US (1) US20040058974A1 (no)
EP (1) EP1542681A2 (no)
JP (1) JP2006503839A (no)
CN (1) CN1688306A (no)
AU (1) AU2003282806A1 (no)
BR (1) BR0314763A (no)
CA (1) CA2499897A1 (no)
MX (1) MXPA05003124A (no)
NO (1) NO20051987L (no)
WO (1) WO2004026303A2 (no)
ZA (1) ZA200502374B (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7406092B2 (en) * 2003-07-21 2008-07-29 Qlogic, Corporation Programmable pseudo virtual lanes for fibre channel systems
GB0409077D0 (en) * 2004-04-23 2004-05-26 Neutec Pharma Plc Treatment of fungal infections
US20060009469A1 (en) * 2004-05-28 2006-01-12 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmacutical compositions of posaconazole
US20060160823A1 (en) * 2004-05-28 2006-07-20 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmaceutical compositions of Posaconazole
UA89793C2 (uk) 2004-08-13 2010-03-10 Шерінг-Плау Лтд. Фармацевтична композиція, яка містить антибіотик, триазол і кортикостероїд
MX2008015275A (es) * 2006-05-30 2009-02-06 Elan Pharma Int Ltd Formulaciones de posaconazol en nanoparticulas.
US9943614B2 (en) 2008-06-17 2018-04-17 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
JP6272224B2 (ja) 2011-07-20 2018-01-31 ブリガム・ヤング・ユニバーシティＢｒｉｇｈａｍ Ｙｏｕｎｇ Ｕｎｉｖｅｒｓｉｔｙ 疎水性セラゲニン化合物、及びそれを組み込む装置
US9694019B2 (en) 2011-09-13 2017-07-04 Brigham Young University Compositions and methods for treating bone diseases and broken bones
US9603859B2 (en) 2011-09-13 2017-03-28 Brigham Young University Methods and products for increasing the rate of healing of tissue wounds
CN104379120A (zh) 2011-12-21 2015-02-25 布莱阿姆青年大学 口腔护理组合物
US9533063B1 (en) 2012-03-01 2017-01-03 Brigham Young University Aerosols incorporating ceragenin compounds and methods of use thereof
EP2846634A2 (en) 2012-05-02 2015-03-18 Brigham Young University Ceragenin particulate materials and methods for making same
CN102755628B (zh) * 2012-07-16 2013-10-23 中国科学院微生物研究所 一种抗真菌的药物组合物
NZ707003A (en) 2012-10-17 2016-04-29 Univ Brigham Young Treatment and prevention of mastitis
EP2941253B1 (en) 2013-01-07 2021-08-11 Brigham Young University Cationic steroid antimicrobial agents for use in treating cancer
US10568893B2 (en) 2013-03-15 2020-02-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
BR112015023747B1 (pt) 2013-03-15 2023-04-18 Brigham Young University Uso de um composto antimicrobiano catiônico esteroide (csa) para a preparação de uma composição para tratar, reduzir, ou prevenir inflamação aguda ou crônica e/ou dor aguda ou crônica associada com uma doença ou um sintoma de doença
US9387215B2 (en) 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US20150203527A1 (en) 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
CA2844321C (en) 2014-02-27 2021-03-16 Brigham Young University Cationic steroidal antimicrobial compounds
US9867836B2 (en) 2014-03-13 2018-01-16 Brigham Young University Lavage and/or infusion using CSA compounds for increasing fertility in a mammal
US10220045B2 (en) 2014-03-13 2019-03-05 Brigham Young University Compositions and methods for forming stabilized compositions with reduced CSA agglomeration
US9931350B2 (en) 2014-03-14 2018-04-03 Brigham Young University Anti-infective and osteogenic compositions and methods of use
US9686966B2 (en) 2014-04-30 2017-06-27 Brigham Young University Methods and apparatus for cleaning or disinfecting a water delivery system
US10238665B2 (en) 2014-06-26 2019-03-26 Brigham Young University Methods for treating fungal infections
US10441595B2 (en) * 2014-06-26 2019-10-15 Brigham Young University Methods for treating fungal infections
US10227376B2 (en) 2014-08-22 2019-03-12 Brigham Young University Radiolabeled cationic steroid antimicrobials and diagnostic methods
US10155788B2 (en) 2014-10-07 2018-12-18 Brigham Young University Cationic steroidal antimicrobial prodrug compositions and uses thereof
WO2016172543A1 (en) 2015-04-22 2016-10-27 Savage Paul B Methods for the synthesis of ceragenins
US9527883B2 (en) 2015-04-22 2016-12-27 Brigham Young University Methods for the synthesis of ceragenins
US9434759B1 (en) 2015-05-18 2016-09-06 Brigham Young University Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity

Also Published As

Publication number Publication date
EP1542681A2 (en) 2005-06-22
CA2499897A1 (en) 2004-04-01
ZA200502374B (en) 2006-12-27
BR0314763A (pt) 2005-07-26
WO2004026303A2 (en) 2004-04-01
CN1688306A (zh) 2005-10-26
JP2006503839A (ja) 2006-02-02
US20040058974A1 (en) 2004-03-25
MXPA05003124A (es) 2005-06-22
WO2004026303A3 (en) 2004-04-29
AU2003282806A1 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
NO20051987L (no) Behandling av soppinfeksjoner.
Nayak et al. Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma
AR043188A1 (es) Metodos y composiciones para el tratamiento de enfermedades y trastornos asociados con niveles elevados de citoquinas proinflamatorias
BR0314943A (pt) Inibidores da proteìna reguladora da condutância transmembrana da fibrose cìstica e usos destes
NO20025601D0 (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
CY1116215T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
HUP0103108A2 (hu) Formoterolt és budesonidot tartalmazó készítmény alkalmazása asztma akut állapotának megelőzésére
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
BRPI0515600A (pt) formas farmacêuticas opióides tendo cmédia e auc em estado estável proporcionais à dose e cmax de dose única inferior ao proporcional à dose
HUP0401998A2 (hu) PDE9 inhibitorok alkalmazása olyan gyógyszer előállítására, amellyel inzulin-rezisztencia szindróma és 2-es típusú diabétesz kezelhető
NO20056252L (no) Terapeutiske og profylaktiske metoder for neuromuskulaere lidelser
CU20000176A7 (es) Composiciones de celecoxib
BR0109779A (pt) Soluções moleculares hidrofìlicas dispersas de carvedilol
NO20072931L (no) Forbedret doseringsregime av temozolomid for behandling av kreft basert pa pasientens MGMT-niva
NO20076245L (no) Anvendelse av TFPI for a behandle alvorlige bakterieinfeksjoner
BR0213292A (pt) tratamento de pneumonia severa por administração de inibidor da via de fator tecidual (tfpi)
Galabov et al. Combination activity of neuraminidase inhibitor oseltamivir and α-tocopherol in influenza virus A (H3N2) infection in mice
HUP9901360A2 (hu) Cimicifuga racemosa-ból származó extraktum alkalmazása
UY26422A1 (es) Método para administrar un inhibidor de fosfodiesterasa 4
PE11399A1 (es) Combinacion de loratadina y un descongestionante para el tratamiento del asma
ATE464052T1 (de) Neue pharmazeutische verwendungen von staurosporin-derivaten
BRPI0414305A (pt) sistema de liberação de drogas por via oral
PT1414467E (pt) Tratamento topico da mastalgia
BR0310061A (pt) Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições
ATE311928T1 (de) (-)-pseudoephedrin als sympathomimetisches arzneimittel